Drug Trial Radar · NCT01087723
European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
Last checked: Nov 20, 2026Latest source record: Feb 12, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,198
Actual
Start
Mar 2010
Primary completion
Aug 2013
Study completion Aug 2014
Sponsor
- Lead sponsor
- The Medicines CompanyIndustry
- Sponsor type
- Industry
- First posted
- Mar 16, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To show that the early administration of bivalirudin improves 30 day outcomes when compared to the current standard of care in participants with ST segment elevation acute coronary syndrome (STE-ACS), intended for a primary percutaneous coronary intervention (PCI) management strategy, presenting either via ambulance or to centers where PCI is not performed.
Conditions
- Acute Coronary Syndrome
Interventions
BivalirudinDrug
HeparinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Composite Incidence of Death and Non-coronary Artery Bypass Graft (CABG) Major BleedingTime frame: Within 30 days
Locations
145 sites in 9 countries. Site status is shown where the registry gives one.
Hanusch Krankenhaus
Vienna, Austria
Magistratsabeilung 70, Wiener
Vienna, Austria
Universitats-Klinik Fur
Vienna, Austria
Wilhelminenspital MA 6 - BA 19
Vienna, Austria
Zdravotnicka Zachranna Sluzba
České Budějovice, Czechia
Aarhus Universitetshospital
Aarhus, Denmark
Akutlaegebil Kobenhavn, Hc Andersens Boulevard 23
Copenhagen, Denmark
Rigshospitalet
Copenhagen, Denmark
Gentofte Hospital
Hellerup, Denmark
Akutlaegebil Nordsjaelland
Hillerød, Denmark
Laegeambulancen Odense
Odense, Denmark
Odense Universitets Hospital
Odense, Denmark
Hopital Europeen Paris La Roseraie
Aubervilliers, France
Hospital Avicenne, Pharmacie -Gestion Des Essais Cliniques
Bobigny, France
Chu De Bordeaux - Hopital Pellegrin
Bordeaux, France
Centre Hospitalier Bourg En Bresse
Bourg-en-Bresse, France
Clinique Convert
Bourg-en-Bresse, France
Ch Jacques Coeur
Bourges, France
Centre Hospitalier Universitaire De Caen
Caen, France
Hopital Prive Saint Martin
Caen, France
Service De Cardiologie
Cedex, France
Ch Chateauroux
Châteauroux, France
Chu Clermont-Ferrand, Hopital
Clermont-Ferrand, France
Samu-Smur Chu Clermont-Ferrand
Clermont-Ferrand, France
Hopital Beaujon
Clichy, France
Ch Sud Francilien - Site Corbeil
Corbeil Essonne, France
Ch Sud Francilien - Site Corbeil, Pharmacie
Corbeil-Essonnes, France
Capio - Clinique Des Cedres
Cornebarrieu, France
Hospital Henri Mondor, Pharmacie
Créteil, France
Samu 92 Hauts De Seine
Garches, France
Clinique Les Eaux Claires Ghm
Grenoble, France
Chu A Michallon Grenoble
La Tronche, France
Samu Chu A Michallon Grenoble
La Tronche, France
Hopital Andre Mignot - Centre Hospitalier De Versailles
Le Chesnay, France
Chr Lille
Lille, France
Samu 59/Samu Du Nord
Lille, France
Centre Hospitalier De Longjumeau
Longjumeau, France
Centre Hospitalier St Joseph St Luc
Lyon, France
Institut Hospitalier Jacques Cartier
Massy, France
Centre Hospitalier De Montelimar
Montélimar, France
Showing 40 of 145 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.